Small study tests High-Dose antibiotic for sepsis
NCT ID NCT07245966
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at how a high dose of the antibiotic ceftriaxone works in 20 adults with sepsis. Researchers measured drug levels in the blood to see if the dose was strong enough to kill bacteria. The goal was to find the best dose to improve survival in sepsis patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ceftriaxone (a broad-spectrum antibiotic)
- What this could lead to
- If successful, this could help doctors choose the right dose of ceftriaxone for sepsis patients, potentially improving survival.
- What could go wrong
- This was a very small study (20 people) that only measured drug levels, not patient outcomes. The results may not apply to all sepsis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, 90110, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?